• Scientific Research Unit (SRU) was founded initially within the FMHS in 2011 as an office to coordinate students’ research projects after establishing the IRB in 2010. It then became an internal responsibility waivered to an assigned staff member supervised of  the Dean/Vice Dean in 2014, with the responsible staff member invited to participate in all FMHS council meetings.
  • In 2018 it was officially approved by ANNU as the SRU with an assigned director recognized as an official member of the FMHS council.
  • With recent 2020 approval of Medical Education Office (MEO), the SRU is a bureau within the MEO that is responsible for coordinating students’ research projects, the clinical research office at NNUH, and all research activity and laboratories at the FMHS. The expansion of SRU demonstrates the importance of commitment to research in the FMHS.

.To improve the health system in Palestine through clinical and translational research

To create the appropriate structure for scientific research, to disseminate its culture, and to enhance the culture of research and study in students of FMHS.

  1. Link the unit's policies in the field of Scientific Research to the vision, mission and goals of the university.
  2. Promote Scientific Research at the FMHS and promote the culture and practice of Scientific Research.
  3. Contribute to the study of community issues and the creation of scientific solutions to solve them.
  4. Develop research strategy, and plan and develop mechanisms for implementation in the medical college.
  5. Provide a data bank related to Scientific Research in FMHS.
  6. Encourage faculty members to participate in conferences and seminars.
  7. Organize research capacity building activities.

The An-Najah IRB is composed of twelve members representing the Faculties of Medicine and Health sciences (with its constituents), Sciences, Arts, Engineering and Physical Education colleges. It also has a university attorney and Sharea'a expert who are familiar with local regulations, as well as two lay individuals who are familiar with human research. There is also an Ex-Officio non-voting member who represents the administration (the Dean of the Faculty of Medicine and Health Sciences). The Board is chaired by Hasan Fitian, MD, who has been charged also with IRB continuous development at the institution. To ensure familiarity with research issues and the issues that led to the formation of the Board, all members complete the online course on Human Participant Protections Education for Research Teams. (http://phrp.nihtraining.com/users/login.php).

Institutional Review Board (IRB)

SRU is Responsible for Scientific Laboratories that are Composed of 5 Research Labs

Focuses on genetics, molecular biochemistry and cell culture in terms of:

  • Detection of different genetic mutations and their relationship to genetic diseases.
  • Molecular medicine and the study of disease at the infectious and molecular level.
  • Effects of different medicines, plants and organic compounds on different types of cells and tissues.
  • Cellular signals and how to regulate them in medical and health conditions.

Microbiology Research Lab Focuses on Microbes in term of:

  • Their cultivation and development in different food environments.
  • Biochemical tests that differentiate them.
  • Their elimination by different sterilization methods.
  • Sensitivity tests for various antibiotics to determine their effectiveness towards microbes.
  • The effect of drugs, plants and various organic compounds on different types of microbes (Bacteria, Fungi, etc.).
  • To design accurate rests to distinguish them and detect appropriate antibiotics to eradicate them.

It was established in 2016 with the primary mission to breed specific laboratory animals free of pathogens for research and education purposes, mainly for the FMHS, although animals are also provided for other departments and units of the university. Lab also provides advice on matters related to laboratory animal science. Lab is divided into three main parts:

  • Stockroom, which includes mice (Balb/c & C57) and hamsters, where reproduction is made upon request.
  • Research room, where the mice are separated according to protocols and scientific research.
  • Procedure room.

The neuroscience research lab on glutamate ion channel receptors (iGluRs). These receptors ‎mediate synaptic neurotransmission and are indispensable in brain activity, such as ‎memory and learning. Upon binding to glutamate, the glutamate receptor rapidly ‎changes its conformation and opens its ion channel pore to allow small cations such as ‎sodium ions to flow across the cellular membrane, transmitting an electrical signal ‎between neurons. Moreover, research will concern the membrane proteins on the cell ‎surface. The activity of virtually every cell is regulated by extracellular signals, such as ‎neurotransmitters, hormones, and sensory stimuli. These signals are transmitted into the ‎cell interior via membrane receptor proteins. Understanding how these membrane ‎proteins mediate signal transmission and transduction is the primary research interest in the neuroscience laboratory. We are particularly interested in the structure and function relationship, ‎the kinetic and molecular mechanism of protein function by protein-protein and protein-drug interactions. We also attempt to develop a better inhibitor/potentiators to regulate ‎membrane protein functions. In the long term, we hope that our research will provide ‎not only insight into the mechanisms of action of these molecular machines but also ‎clues for the design of molecular devices which can be used (i) for studying signal ‎transduction pathways and (ii) as diagnostic/detection tools for disease treatment. We ‎use an interdisciplinary approach in our research, including rapid kinetic techniques ‎suitable for membrane proteins, biochemical and biophysical chemistry, molecular ‎biology, electrophysiology, and neuroscience.‎

Neuroscience Lab Biography

 Conducts basic, translational, and clinical research to develop novel drugs to assist the body in killing cancer cells and develop optimal conditions to regrow, repair or replace damaged or diseased cells, organs or tissues.

The aim is to translate findings into clinical trials that make a difference in the lives of patients (from bench to bedside) as we work in tandem with academic and industry colleagues. The goals are to identify critical genes and pathways that distinguish cancer from normal (Stem) cells, isolate tissue-specific stem cells and define the conditions that are required to repair damaged tissues, develop novel drugs for cancer therapy and regenerative medicine, fix defective, disease-causing genes (Gene Therapy) and re-growth of damaged tissues (Body Parts).

An-Najah Center for Cancer and Stem Cell Research